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Marine snails of the Conus genus produce venom, composed of a range of bioactive disulfide-rich peptides known as conotoxins, that is used for both defense and for prey capture.
[1] Members of the α-conotoxin subfamily (Figure 1 ) are defined as neuronal or muscle nicotinic acetylcholine receptors (nAChRs) antagonists.
[2]
Figure 1. Selected -conotoxins and their conserved structural framework. (A) Sequences of -conotoxins that inhibit high voltage-activated (HVA) calcium channel currents (I Ca ) via the GABA B receptor (in red) and homologous sequences that have been investigated in this study (in black). The boxes indicate groupings of homologous sequences; cysteines are highlighted in yellow and numbered with Roman numerals, and the native CysI -CysIII, CysII -CysIV connectivity is indicated by solid black lines (top). An asterix indicates an amidated C-terminus. The two loops of the -conotoxins are indicated at the bottom. (B) A schematic illustration of the three possible disulfide isomers for an -conotoxin: the globular isomer (CysI -CysIII, CysII -CysIV, top), the ribbon isomer (CysICysIV, CysII -CysIII, middle), and bead isomer (CysI -CysII, CysIII -CysIV, bottom). (C) The three-dimensional structure of Vc1.1 highlighting the helical nature of the -conotoxins, the cysteine framework (Roman numerals), the two disulfide bonds (yellow ball and sticks) and the two sequence loops.
α-Conotoxins Vc1.1 [3] and RgIA [4] have been of recent interest as drug leads, because they have analgesic properties in rat models of neuropathic pain. [5] Recently, a backbone cyclisation strategy was used to develop an orally active analogue of Vc1.1. [6] Vc1.1 and RgIA are α9α10 nAChR subtype antagonists, and potently inhibit N-type (Ca v 2.2) and R-type (Ca v 2.3) calcium channels via GABA B receptor (GABA B R) activation. [7] GABA B R agonists have been shown to relieve neuropathic and chronic pain.
[8]
Subsequently, three other conotoxins, PeIA [9] , AuIB [5d] and Vc1.2 [10] , have also been shown to inhibit HVA calcium channels via a GABA B R-dependent mechanism (Fig 1A) .
α-Conotoxins contain four cysteine residues, so can potentially form three disulfide isomers during oxidative folding (Fig 1B) . These include the globular isomer (CysI-CysIII and CysII-CysIV), the ribbon isomer (CysI-CysIV and CysII-CysIII) and the beads isomer (CysI-CysII and CysIII-CysIV). The natively preferred disulfide connectivity for wild-type α-conotoxins is typically the globular isomer although the ribbon isomer of the α-conotoxin ImI was detected in the venom of Conus imperialis. [11] The three dimensional structure of the α-conotoxin globular isomer consists of a helical turn that is cross-braced by two disulfide bonds (Fig 1C) . This structure orientates the side chains of the peptide to facilitate the binding of the conotoxin between two subunits of the pentameric nAChR.
[12] Interestingly, the ribbon isomer of several α-conotoxins has been shown to inhibit nAChRs.
[13] Therefore, exploring the effect of disulfide connectivity could provide valuable information on structure/activity relationships, and lead to the discovery of new bioactive molecules.
Here we focus on expanding our knowledge of the sequence and structural diversity of α-conotoxins that target the GABA B R. Based on sequence homology to Vc1.1, RgIA, AuIB or PeIA, we chose six α-conotoxins from the ConoServer database ( Figure  1A) . [14] The globular isomers of each peptide were synthesized by Fmoc solid-phase peptide synthesis with regioselective disulfide bond formation using S-acetamidomethyl (Acm) protection on CysI and CysIII. Peptides were obtained in high purity and acceptable yield (6 to 18%) after HPLC purification ( Figure S1 ).
The purified globular isomers for all six peptides gave well dispersed signals in their 1 H NMR spectra, implying they adopt ordered structures in solution. They were further analyzed by two-dimensional NMR and secondary Hα shift analysis showed the peptides adopted a fold consistent with other α-conotoxins ( Figure S3A-C) , including a series of negative secondary shift values in the central portion of the peptide that is indicative of helical secondary structure. [15] The conotoxins were tested for their ability to inhibit HVA calcium channel currents (I Ca ) in rat DRG neurons. α-Conotoxins Pn1.2, Pu1.2, Kn1.2 and Tx1.2 inhibited I Ca by ~22, 27, 13 and 8%, respectively. In comparison, Ai1.2 and Bu1.1 did not modulate I Ca (Figures 2A and S9 ). These results expand the known number and sequence diversity of α-conotoxins that inhibit HVA calcium channel currents. It was previously shown that non-native disulfide isomers of α-conotoxins are biologically active.
[13] Therefore, to explore the structural elements required for calcium channel inhibition via GABA B Rs, we synthesized the three possible disulfide isomers of Pn1.2, plus Pu1.2 and Vc1.1.
As described for the globular isomer syntheses, we used Fmoc SPPS and Acm protection on specific pairs of cysteines to produce the ribbon and beads isomers of Pn1.2, Pu1.2 and Vc1.1. NMR analyses revealed that all isomers adopted a single conformation in solution, except for the Pn1.2 globular isomer and all three beads' isomers. These peptides showed other minor conformations, presumably due to proline cis/trans isomerization. However this was only confirmed for the Pn1.2 globular isomer (Table S1 ). Chemical shift assignments and secondary shift analyses for all disulfide isomers are given in Tables S2-4 and Figure S4 . Surprisingly, all isomers inhibited I Ca in rat DRG neurons ( Figure 2B ) and there was no significant difference in inhibitory activity between individual isomers of each peptide. All α-conotoxin isomers were stable during the assay and no disulfide shuffling between isomers was observed ( Figure S8 ). We have shown that both reduced and alkylated Vc1.1 have no effect on HVA calcium channel currents.
[7] Therefore, the observed activity can be attributed to specific isomers and suggests there might be a common bioactive motif between each isomer. To further understand the common structural elements in the three isomers, we determined the three dimensional structures of the globular, ribbon and beads isomers of Pu1.2. Structures were calculated in CYANA 3.0 [16] and refined in CNS [17] using NOE derived distance restraints, TALOS-N [18] derived dihedral angle restraints, and hydrogen bond restraints from D 2 O exchange experiments. The structural statistics for the ensemble of the 20 lowest energy structures for each isomer are shown in Table S5 . Figure 3 shows the lowest energy structure from each structural ensemble.
Both the globular and ribbon isomers had well-defined structures, with the globular isomer possessing the characteristic helical nature of an α-conotoxin. The beads isomer had two defined loop regions (Gly2-Pro8) and (Cys9-Cys16), separated by a flexible hinge ( Figure S6 ). The surface features of all three isomers consist of a series of alternating polar and hydrophobic patches, with the major hydrophobic region formed by Pro7, Pro8, Ile10 and Ala11 ( Figure S7 ). There were no obvious structural similarities between the three isomers, but there was some indication of common loop motifs. For example, the backbone RMSD from residues Cys3-Pro8 for all 60 structures was only 0.954 Å. ; and (C) beads (blue) disulfide isomers of -conotoxin Pu1.2. The structure shown for each isomer is the lowest energy conformer from an ensemble of the 20 lowest energy structures calculated using CYANA [16] and refined in CNS [17] . Structures are shown in ribbon format with disulfide bonds in ball and stick, and the cysteines and N and C termini labelled.
To see if any loop regions in the Pu1.2 isomers form the core requirement for calcium channel inhibition, we made a set of truncated and disulfide deficient Pu1.2 mutants ( Figure 4A ). These consisted of full-length ([Ser 1(1-8) , revealed it inhibited HVA calcium currents in mouse DRG neurons with a potency comparable with full-length Vc1.1 ( Figure 4C ). These truncated, single disulfide conotoxin analogues could be promising lead molecules for the development of new analgesics.
Vc1.1, RgIA and their backbone cyclic analogues have all been proposed as potential leads for drugs to treat neuropathic and chronic pain. Compared with these full-length peptides, the truncated versions have the advantage of structural simplicity, making their synthesis faster, less expensive and more efficient. Of note is that loop 1 of Vc1.1 and RgIA is also identical in sequence to that of ImI, which did not inhibit HVA calcium currents in rat DRG neurons.
[7b] This suggests residues in loop 2 can also influence interactions with GABA B R, which is consistent with our previous study showing that post-translational modification of Glu 14 in Vc1.1 to -carboxyglutamic acid resulted in a loss of HVA calcium channel inhibitory activity.
[7b] Furthermore, post-translational modification of Pro 6 of Vc1.1 to hydroxyproline also caused a loss of HVA calcium current inhibition suggesting that this residue, which is present in both [Ser 3 ]Vc1.1(1-8) and [Ser 4 ]Pu1.2(1-9), might be a key interaction site with the GABA B R. 
